KNSA

Kiniksa Pharmaceuticals Ltd. Class A (KNSA)

About Kiniksa Pharmaceuticals Ltd. Class A (KNSA)

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Details

Daily high

$24.63

Daily low

$23.64

Price at open

$23.93

52 Week High

$27.92

52 Week Low

$14.12

Market cap

1.7B

Dividend yield

0.00%

Volume

266,108

Avg. volume

475,102

P/E ratio

-152.31

Kiniksa Pharmaceuticals Ltd. Class A News